Janux Therapeutics Inc. (JANX)
Market Open
20 Jul, 13:37
NASDAQ (NMS) NASDAQ (NMS) Primary $
16. 41
+0.15
+0.9533%
$
962.33M Market Cap
- P/E Ratio
- Div Yield
23,284 Volume
-1.35 Eps
$ 16.26
Previous Close 
Want to track JANX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
JANX Earnings Reports FAQ
What is the earnings per share (EPS) for JANX?
The current EPS is -1.35.
What is the company's earnings growth rate?
Janux Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Janux Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Janux Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for JANX at this time, as Janux Therapeutics Inc has no recent EPS data to calculate it.
